AVTX AVALO THERAPEUTICS INC

Ownership history in BVF INC/IL  ·  6 quarters on record

This page tracks every 13F SEC filing in which BVF INC/IL reported a position in AVALO THERAPEUTICS INC (AVTX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.83% (2025 Q4)
Avg. % of fund
0.43%
First filed
2024 Q3
Last filed
2025 Q4
Quarters held
6
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 1,355,257 +1 +0.0% 0.83% $24.6M $18.16
2025 Q3 ADDED 1,355,256 +327,207 +31.8% 0.70% $17.2M $12.71
2025 Q2 REDUCED 1,028,049 -8,630 -0.8% 0.18% $5.1M $4.99
2025 Q1 UNCHANGED 1,036,679 0% 0.34% $8.3M $8.01
2 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    AVTX price (monthly, adj. close)
← Back to BVF INC/IL Holdings